# Weight loss drug manufacturer Eli Lilly's market share in India declined in March.

*business · news · 2026-04-10 · NDTV Profit*

## Key points

- Eli Lilly's market share in India dropped from 61% to 56% in March 2024.
- Novo Nordisk's market share in India remained steady at 25% despite generic competition.
- Thirteen Indian companies launched 26 semaglutide brands within weeks of the patent expiry.
- Eli Lilly's Mounjaro is priced at least twice as high as Novo's and ten times generic versions.
- Experts predict further erosion of Eli Lilly's sales as cheaper generics proliferate in the market.

**Companies:** Eli Lilly, Novo Nordisk, Dr Reddy's Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Biocon Ltd., Lupin Ltd.
**Countries:** India

[Read the full story on NDTV Profit](https://www.ndtvprofit.com/business/patent-cliff-impact-eli-lilly-market-share-stumbles-as-generic-weight-loss-drugs-gain-ground-in-india-11338871)

---

Canonical: https://newsio.io/n/97ea8b7e-58f4-4e63-bb28-b3fd585744f3/weight-loss-drug-manufacturer-eli-lillys-market-share-in-india-declined-in-march
Summarized by Newsio from NDTV Profit. https://newsio.io/how-it-works